Abstract
Protein kinases are key factors in signal transduction, playing a pivotal role in the initiation, propagation and regulation of immunologic responses. In contrast to protein- protein interaction they are considered to be “drugable” by small molecular weight inhibitors. Thus kinases moved into in the focus as promising drug targets for the therapy of inflammatory and autoimmune diseases. Whereas some kinase inhibitors are in clinical development already, most others are in early stages of research or still require validation. Recently, major progress has been made in elucidating the complete human kinome, in understanding molecular mechanisms of protein kinase action in inflammation as well as in regard to technologies suitable for in vitro and in vivo target validation, inhibitor screening and its structural refinement. Starting with some general points, this review summarise some recent findings and developments and prepare the stage for the subsequent review articles published in this hot topic issue. It is the purpose to highlight both the opportunities and the issues associated with kinases as drug targets and to enable the reader to keep up with this fast developing field, that is of substantial interest for basic and applied scientists.
Keywords: Drug targets, Inflammation, Immune regulation, Inhibitors, Kinases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Protein Kinase Inhibitors for the Treatment of Inflammation - An Overview
Volume: 6 Issue: 1
Author(s): Khusru Asadullah and Matthias Gaestel
Affiliation:
Keywords: Drug targets, Inflammation, Immune regulation, Inhibitors, Kinases
Abstract: Protein kinases are key factors in signal transduction, playing a pivotal role in the initiation, propagation and regulation of immunologic responses. In contrast to protein- protein interaction they are considered to be “drugable” by small molecular weight inhibitors. Thus kinases moved into in the focus as promising drug targets for the therapy of inflammatory and autoimmune diseases. Whereas some kinase inhibitors are in clinical development already, most others are in early stages of research or still require validation. Recently, major progress has been made in elucidating the complete human kinome, in understanding molecular mechanisms of protein kinase action in inflammation as well as in regard to technologies suitable for in vitro and in vivo target validation, inhibitor screening and its structural refinement. Starting with some general points, this review summarise some recent findings and developments and prepare the stage for the subsequent review articles published in this hot topic issue. It is the purpose to highlight both the opportunities and the issues associated with kinases as drug targets and to enable the reader to keep up with this fast developing field, that is of substantial interest for basic and applied scientists.
Export Options
About this article
Cite this article as:
Asadullah Khusru and Gaestel Matthias, Protein Kinase Inhibitors for the Treatment of Inflammation - An Overview, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (1) . https://dx.doi.org/10.2174/187152307779939769
DOI https://dx.doi.org/10.2174/187152307779939769 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective
Current Neurovascular Research Lymphoid-Specific Tyrosine Phosphatase (Lyp): A Potential Drug Target For Treatment of Autoimmune Diseases
Current Drug Targets Immunopathology of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Generation of Regulatory T Cells to Antigen Expressed in the Retina
Current Immunology Reviews (Discontinued) Immunogenicity in Protein and Peptide Based-Therapeutics: An Overview
Current Protein & Peptide Science Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design B Lymphocytes, Potent Antigen Presenting Cells for Preferential Expansion of Allo-Reactive FoxP3+ CD4 Regulatory T Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders
Reviews on Recent Clinical Trials Role of C1858T Polymorphism of Lymphoid Tyrosine Phosphatase in Egyptian Children and Adolescents with Type 1 Diabetes
Current Diabetes Reviews Randomized Controlled Trials in Prevention of PostSurgical Recurrence in Crohn’s Disease
Reviews on Recent Clinical Trials Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
Current Topics in Medicinal Chemistry Alpha 4 Integrin Antagonists
Current Pharmaceutical Design Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases
Current Drug Targets Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Celastrol and Terpenes as Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design PROGRAMMED Cell Clearance: Molecular Mechanisms and Role in Autoimmune Disease, Chronic Inflammation, and Anti-Cancer Immune Responses
Current Immunology Reviews (Discontinued) Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences
Central Nervous System Agents in Medicinal Chemistry